Leaflet FULVESTRANT TEVA 250mg solution for injection in pre-filled syringe
Indicated for: breast cancer
Route of administration: injectable
Substance: fulvestrant (antineoplastic agent)
ATC: L02BA03 (Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-estrogens)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Fulvestrant is a medication used to treat advanced breast cancer in postmenopausal women, especially when the disease is hormone-sensitive. It works by blocking estrogen receptors on cancer cells, thereby preventing their growth and multiplication.
Fulvestrant is administered by intramuscular injection, usually once a month, under medical supervision. The dose and treatment schedule are determined by your doctor based on the stage of the disease and response to therapy. It is important to follow the treatment regularly to achieve the best results.
Side effects may include pain at the injection site, fatigue, nausea, bone or joint pain, and hot flashes. In rare cases, allergic reactions or changes in liver function may occur. Any unusual symptoms should be reported to your doctor immediately.
Fulvestrant is an effective option for controlling advanced breast cancer, but it requires careful medical monitoring. Follow your doctor's instructions and do not stop treatment without their approval to ensure the therapy's effectiveness and safety.
General data about FULVESTRANT TEVA 250mg
- Substance: fulvestrant
- Date of latest medicines list: 01-06-2026
- Product code: W62773002
- Concentration: 250mg
- Pharmaceutical form: solution for injection in pre-filled syringe
- Quantity: 2
- Product type: Generic medicine
- Price: 927.45 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for fulvestrant
Concentrations available for fulvestrant
- 250mg
- 250mg/5ml